International Tobacco Harm Reduction Advocates Urge Bangladesh to Reconsider Ban Proposal

Aug.22.2022
International Tobacco Harm Reduction Advocates Urge Bangladesh to Reconsider Ban Proposal
International tobacco harm reduction advocates urge Bangladesh authorities to reconsider proposed ban on e-cigarettes and smokeless nicotine products.

A group of international advocates for harm reduction in tobacco have written a letter to the Ministry of Health, calling on the authorities in Bangladesh to reconsider their proposed ban on electronic cigarettes and other smokeless nicotine alternatives.


The letter points out that smokeless nicotine products have the potential to help people quit smoking, and urges the Bangladesh government to ban less harmful cigarette alternatives.


The Bangladeshi government should encourage a shift from traditional cigarettes to e-cigarettes on a large scale and take swift action to minimize illnesses related to smoking, in order to protect smokers. This is according to a statement released.


According to the letter, the authorities in Bangladesh should establish a science-based tobacco control and harm reduction policy, which would "result in public health benefits.


This letter is a response to the recent discussions around the 2013 revision of the 2005 Smoking and Tobacco Products (Control) Act, which includes a new "ban on electronic cigarettes.


The author of this letter believes that the proposed ban would have an impact on protecting the major tobacco companies' cigarette trade and existing commercial interests, even as these companies are attempting to shift towards marketing lower-risk products.


The letter requests that the government of Bangladesh "accept reduced-harm tobacco products as a part of tobacco control in Bangladesh," stating that this "will meet the needs of those who cannot or are unwilling to quit smoking altogether.


The author warned that banning or excessively regulating e-cigarettes without considering the impact on smoking, could easily exacerbate the harm to public health by either sustaining smoking or stimulating black market activity.


The letter urges government authorities to adopt a proportionate approach in regulating electronic cigarettes to address the health issues caused by traditional tobacco cigarettes.


It is suggested that electronic cigarettes should be used to reduce smoking, which is the primary form of tobacco use in Bangladesh. The article emphasizes that electronic cigarettes should be seen as an opportunity rather than a risk.


The letter also provides several pieces of scientific evidence indicating that the harm caused by electronic cigarettes is far less than that of smoking.


In 2018, independent experts from the UK Public Health Department reviewed biomarker data and came to the conclusion that vaping only poses a small fraction of the risk of smoking, and completely switching from smoking to vaping can bring significant health benefits. Based on current knowledge, highlighting that vaping is at least 95% less harmful than smoking is an effective way to communicate the large differences in relative risk, and can encourage more smokers to make the switch to vaping, the letter states.


The letter urges Bangladesh to establish adequate regulations in line with the risks associated with tobacco, emphasizing that the primary objective of the country's tobacco policy should be to prevent and control the high rates of mortality and morbidity associated with tobacco.


The new regulatory system can set age limits, product standards, labeling, marketing and usage restrictions at its discretion, rather than imposing outright bans. The letter suggests that Bangladesh has the opportunity to learn from the experiences of the UK, EU and other places where there are valuable lessons to be learned.


Experts emphasize that in the proportional risk approach, products with the highest risk face the strictest regulations, while substitutes with lower risk face fewer and lighter restrictions.


Prohibition is the worst policy choice as it deprives law-abiding smokers of safer options, creates a black market, increases crime and corruption, ultimately burdening law enforcement agencies.


The main form of tobacco use in Bangladesh is through the use of e-cigarettes, which should be used as a means to reduce smoking, according to a letter. The letter indicates that e-cigarettes should be viewed as an opportunity rather than a risk.


The letter was signed by 17 individuals, including Dr. Delon Human, a former advisor to both the Director-General of the World Health Organization and the United Nations Secretary-General Ban Ki-moon.


Other signatories include Dr. Andres Milton, President of the European Red Cross and Red Crescent Network on HIV/AIDS and Tuberculosis, as well as scholars from Sweden, New Zealand, and Germany such as Professor Marewa Glover of Public Health at the University of Auckland and Professor Heino Stöver of Social Science Addiction Research at Frankfurt University of Applied Sciences.


Statement:


This article is compiled from third-party information and is intended for industry professionals for exchange and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The translation of this article is solely for internal communication and research within the industry.


Due to limitations in our translation skills, the translated article may not fully convey the meaning of the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, or foreign related issues and positions.


The copyright of the compiled information belongs to the original media and author, and if there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

EU TPD Revision May Slip to 2027: Parliament Backs Wider Nicotine Rules by 447 Votes as Commission Impact Assessment Reportedly Receives Negative Opinion
EU TPD Revision May Slip to 2027: Parliament Backs Wider Nicotine Rules by 447 Votes as Commission Impact Assessment Reportedly Receives Negative Opinion
On Nov 12, 2026, the European Parliament adopted a resolution on implementing Europe’s Beating Cancer Plan by 447 votes to 66, with 91 abstentions, urging the European Commission to speed up revisions to the Tobacco Products Directive (TPD) and Tobacco Advertising Directive (TAD). Parliament called for broader regulation of e-cigarettes, heated tobacco, nicotine pouches and other emerging nicotine products, proposing measures on packaging, health warnings, flavors, ingredient reporting, online age verification, digital marketing and premarket health impact assessments. EUNews and others reported that the Commission’s Regulatory Scrutiny Board (RSB) issued a negative opinion on the revisions’ impact assessment on Nov 9. The Commission had scheduled the initiative for December 2026, but the reported setback could push the legislative proposal into 2027. No revised official timetable has been announced, and Parliament’s resolution does not amend existing EU law.
Regulations
Nov.19
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa plans to publish its first vapor products directory on November 16, 2026, after which products not listed will be prohibited from sale or offer for sale in the state. The Department of Revenue expects to begin penalty enforcement on December 17, following an initial 21-business-day period focused on compliance education. Under House File 2677, retailers, distributors and wholesalers selling unlisted products face civil penalties of $300 per product per day, while manufacturers face $1,000 per product per day. Eligibility extends to FDA-authorized products and certain products meeting historical marketing and pending PMTA requirements. The directory program resumed after a federal appeals court vacated a preliminary injunction in July 2026.
Regulations
Nov.05
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
Imperial Brands Plans to Cut Nearly 18% of Workforce as German Plant Closure and Polish Outsourcing Drive Restructuring
Imperial Brands Plans to Cut Nearly 18% of Workforce as German Plant Closure and Polish Outsourcing Drive Restructuring
Imperial Brands disclosed on November 17, 2026, that its global manufacturing and organisational restructuring is expected to reduce between 4,200 and 4,600 roles by the end of 2030, equivalent to approximately 16%–18% of its workforce at the end of 2025. The first phase covers 2,100 roles with departures confirmed or subject to consultation, while a further 2,100–2,500 positions are expected to be eliminated by 2030. The company is proceeding with the closure of its Langenhagen factory in Germany, has sold its manufacturing facility in Taiwan, and has transferred selected finance, procurement and supply-chain operations in Poland to Capgemini. The restructuring programme is expected to cost approximately £740 million, with Imperial targeting at least £320 million in annual cost savings by 2030.
company
Nov.18